Integrated Protein Technologies, Inc.

Evanston, IL · Biotech · Private

SampleStream technology—a rapid purification and concentration system for large proteins coupled to immunoprecipitation and mass spectrometry analysis to identify and quantify disease-specific antibod

Grants
$2.9M
6 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
5
3 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: SampleStream: A Sample Preparation Platform for Biologics$224,218
Federal grantDepartment of Health and Human Services · Phase I · SampleStream A Radically Simplified Platform for Protein Sample Preparation$146,612
Federal grantDepartment of Health and Human Services · Phase II · SampleStream: A Radically Simplified Platform for Protein Sample Preparation$1,598,501
Federal grantDepartment of Health and Human Services · Phase II · Making the SampleStream Platform a Medical Device$285,250
Federal grantDepartment of Health and Human Services · Phase II · SampleStream: A Radically Simplified Platform for Protein Sample Preparation$321,321
Federal grantDepartment of Health and Human Services · Phase II · SampleStream: A Radically Simplified Platform for Protein Sample Preparation$318,151
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1405CRYOCRATE LLC——
1406DD Therapeutics, LLC——
1407Bedrock Therapeutics, Inc.——
1408Integrated Protein Technologies, Inc.——
1409PHOTONIC PHARMA, LLC——
1410GIGAMUNE, INC.——
1411Complex Computation, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 3 granted of 5

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.